Commonwealth Equity Services
IPCI

Commonwealth Equity Services’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Commonwealth Equity Services’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,026
Closed -$26K – 2587
2017
Q1 		$26K Buy
+1,026
New +$26.4K ﹤0.01% 2366

Other funds holding IPCI

FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ATC
Argent Trust Co Nashville, Tennessee $2.95B AUM 22.66% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Commonwealth Equity Services's IPCI Position: Q2 2017 in Review

Commonwealth Equity Services sold out of Intellipharmaceuticals International Inc. (IPCI) in Q2 2017, closing a stake of 1,026 shares — an estimated $26K sold.

Commonwealth Equity Services first reported a position in IPCI in Q1 2017 and held it in 1 quarter. The position peaked at $26K in Q1 2017. 19 funds tracked by Wall St. Rank hold IPCI as of Q2 2017.

  • Commonwealth Equity Services reported no remaining Intellipharmaceuticals International Inc. position as of Q2 2017 after selling out during the quarter.
  • Commonwealth Equity Services sold 1,026 Intellipharmaceuticals International Inc. shares in Q2 2017, an estimated $26K.
  • Commonwealth Equity Services first reported a position in Intellipharmaceuticals International Inc. in Q1 2017 and held it in 1 quarter.
  • Commonwealth Equity Services's Intellipharmaceuticals International Inc. position peaked at $26K in Q1 2017.
  • 19 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q2 2017.

Based on Commonwealth Equity Services's 13F filing for Q2 2017, filed 11 Aug 2017.